ArticleFrontiers in public health2026
Emotional-cognitive integration in aging: the role of alexithymia in mild cognitive impairment.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Aging is accompanied by a range of cognitive and emotional changes. Among these, difficulty in identifying and describing feelings and a tendency toward externally oriented thinking have been associated with frank cognitive decline. This pattern is known as alexithymia and reflects emotional dysregulation. Methods: Three hundred and twenty adults aged 50-80 years classified as healthy controls, amnestic MCI (aMCI), or non-amnestic MCI (naMCI), completed a comprehensive neuropsychological assessment and the 20-item Toronto Alexithymia Scale (TAS-20). Results and discussion: Participants with aMCI showed significantly higher levels of alexithymia, compared to healthy controls. This pattern suggests that emotional dysregulation is more pronounced in individuals with memory-related cognitive decline. In both the aMCI and naMCI groups, correlations between alexithymia scores and cognitive measures were negative, indicating that higher alexithymia was associated with poorer cognitive performance. In contrast, these associations were weak in healthy controls, implying that the link between emotional processing difficulties and cognitive inefficiency emerges primarily in MCI. Taken together, these findings point to a specific interplay between emotional and cognitive domains in the early stages of neurodegenerative decline. Accordingly, elevated alexithymia in aMCI individuals might represent a socio-emotional marker of prodromal Alzheimer's disease, highlighting the importance of considering emotional regulation in the assessment of cognitive aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.